SCHEMBL2084716

SCHEMBL2084716

CC(C)(c1ccccc1)c1cccnc1C=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 4/20 0.35
ESR1 P03372 1/20 0.35
CYP3A4 P08684 1/20 0.35
ESR2 Q92731 1/20 0.35
MAPK1 P28482 1/20 0.34
NFE2L2 Q16236 6/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
CHRM1 P11229 1/20 0.34
CHRM3 P20309 1/20 0.34
TRIM24 O15164 1/20 0.33
TRIM33 Q9UPN9 1/20 0.33
NR3C2 P08235 2/20 0.33
ALOX15 P16050 1/20 0.32
MEN1 O00255 1/20 0.32
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2082864 0.86 CYP19A1 (0.41) ALDH1A1CYP3A4NFE2L2MEN1LMNA
SCHEMBL2082081 0.86 NFE2L2 (0.38) NFE2L2MEN1KMT2A
SCHEMBL80776 0.80 TRIM24 (0.38) KDM4EALDH1A1NFE2L2TRIM24TRIM33
SCHEMBL2083546 0.75 CYP3A4 (0.39) KDM4EALDH1A1ESR1CYP3A4ESR2
SCHEMBL2085731 0.75 NFE2L2 (0.40) KDM4EALDH1A1NFE2L2TRIM24TRIM33
SCHEMBL17508181 0.73 KMT2A (0.46) ALDH1A1ESR1CYP3A4ESR2MAPK1
SCHEMBL586118 0.73 NFE2L2 (0.48) NFE2L2TRIM24TRIM33LMNA
SCHEMBL2199266 0.71 ALDH1A1 (0.54) ALDH1A1ESR1CYP3A4ESR2MAPK1
SCHEMBL22212665 0.70 NFE2L2 (0.39) KDM4EALDH1A1NFE2L2TRIM24TRIM33
SCHEMBL2085967 0.70 ALDH1A1 (0.46) KDM4EALDH1A1ESR1CYP3A4ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613613-B1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS GENZYME CORP (US) 2021-06-02 EP disclosed
WO-2021083018-A1 PREPARATION METHOD FOR AND APPLICATION OF 3-SUBSTITUTED CHIRAL SPIRO AMINOPHOSPHINE LIGAND ON PYRIDINE RING 浙江九洲药业股份有限公司 2021-05-06 WO disclosed
US-7863293-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2011-01-04 US disclosed
EP-1613613-A4 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2009-03-25 EP disclosed
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED CORPORATION (CA) 2008-10-16 US disclosed
US-7291631-B2 CXCR4 chemokine receptor binding compounds GENZYME CORPORATION (US) 2007-11-06 US disclosed
EP-1613613-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-01-11 EP disclosed
WO-2004091518-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2004-10-28 WO disclosed
US-20040209921-A1 CXCR4 chemokine receptor binding comounds ANORMED CORPORATION (CA) 2004-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209921-A1 CXCR4 chemokine receptor binding comounds CXCR4, CXCR1, CXCR3 KDM4E 3901/4885ALDH1A1 357/4885ESR1 896/4885
US-20080255197-A1 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS CXCR4, CXCR1, CXCR3 KDM4E 3210/4885ALDH1A1 424/4885ESR1 747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.